Pathos AI teams up with Bristol Myers and Tempus AI to advance drug development

2

Oct 23 (Reuters) – Pathos AI said on Friday it had entered into a collaboration with Bristol Myers Squibb and Tempus AI to develop artificial intelligence tools for drug development in Alzheimer's

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)